The replacement of fetal by adult hemoglobin after birth is not complete, since small amounts of fetal hemoglobin are consistently present in the blood of normal adults (6-9). It is, therefore, of interest to learn how continued synthesis of fetal hemoglobin in the adult is regulated and whether it can be further stimulated. We examined this in vitro, with a bone marrow culture system which permits selective proliferation of erythroid cells (10). We report here data which suggest appearance of increased and clonal synthesis of fetal hemoglobin in the adult erythroid cells, in vitro. METHODS Bone Marrow Cultures. Bone marrow aspirates from healthy volunteers without a hemoglobinopathy and from a patient homozygous for hemoglobin S were used; on a few occasions ribs surgically removed from patients were the source of marrow cells. Cells were washed in medium (Microbiological Associates, Bethesda, Md.) containing 2% (vol/vol) fetal calf serum, penicillin (50 units/ml) and streptomycin (50 ,gg/ml); the buffy coat layers were removed, and resuspended in fresh media. Antibodies and Immunofluorescent Labeling. Antibodies against hemoglobin F (anti-Hb F) or A (anti-Hb A) were raised in rabbits (anti-Hb F) or horses (anti-Hb A) and purified by affinity chromatography. The purification procedure, the conjugation with fluorescein isothiocyanate (FITC), and evidence of specificity of the anti-Hb F antibodies have been described (9). Peripheral blood smears were fixed and labeled with anti-Hb F antibodies conjugated with FITC (anti-Hb F-FITC), as previously described (9); smears prepared from bone marrow cell suspensions were treated similarly. Flattened plasma clots were fixed for 12 min in an acetone-methanol (9:1 vol/vol) solution, rinsed for 2 min in phosphate-buffered saline at pH 7.0 (9), rinsed in distilled water for another 2 min, and dried. They were labeled with anti-Hb F-FITC in the same fashion as the smears, except that the whole area of the clot was covered with the fluorescent antibody. After incubation for 1 hr in a humidified chamber at 370, the slides with clots were rinsed in phosphate-buffered saline, then in water, and then dried. They were mounted with clear serum, and viewed in the fluorescent microscope (Zeiss, Universal fluorescence microscope with reflected light excitation) under 150-times magnification. Freshly thawed antibody solutions were used for each experiment and conditions of fixation, staining, and viewing were kept constant. Evaluation of fluorescent labeling was best when plasma clots contained fewer erythroid colonies: cultures inoculated with 5 X 104 nucleated cells per clot were optimal. The reaction of the fixed plasma clots with the fluorescent antihemoglobin antibodies preserved the morphological characteristics of the cells and permitted identification and quantitative estimates of total erythroid colonies under fluorescent light. Erythroid cells and colonies were classified into categories according to intensity of fluorescent labeling. Fluorescence of moderate to bright intensity was considered as evidence for intracellular presence of the hemoglobin detected by the fluorescent antibody.
ABSTRACT
The regulation of fetal hemoglobin in adult erythroid cells was investigated with bone marrow cultures. Fetal hemoglobin (Hb F) was identified in individual erythroid colonies with fluorescent antibodies against Hb F and synthesis of y chains was determined with analyses of radioactive globins. The appearance of fetal hemoglobin in erythroid colonies was clonal. All the cells of the Hb F synthesizing colonies contained fetal hemoglobin. The frequency of erythroid colonies showing Hb F was higher than expected compared to the frequency of Hb F containing cells in the blood. Production of Hb F in culture, as shown by analysis of the radioactive globins, was 5 to 14 times higher than baseline Hb F synthesis. These results suggest that the ability for y chain synthesis in erythroid cells is determined at or above the level of the precursor cell from which the erythroid colonies, in vitro, derive (probably an erythropoietin responsive stem cell), and that stimulation of fetal hemoglobin synthesis in adult erythroid cells is possible. In man, and a few other mammals, fetal hemoglobin (Hb F, chain composition ay272, is the predominant hemoglobin of the fetus and it is replaced by adult hemoglobin (Hb A: a2.2) soon after birth. Although hypotheses to explain this switch from y to fi globin formation in man have been proposed (1) (2) (3) (4) (5) , the factors involved in this process are unknown. Delineation of the mechanisms of regulation of fetal hemoglobin in man, however, might be of considerable biological interest and of possible practical importance for treatment of sickle cell anemia and homozygous ,f-thalassemia.
The replacement of fetal by adult hemoglobin after birth is not complete, since small amounts of fetal hemoglobin are consistently present in the blood of normal adults (6) (7) (8) (9) . It is, therefore, of interest to learn how continued synthesis of fetal hemoglobin in the adult is regulated and whether it can be further stimulated. We examined this in vitro, with a bone marrow culture system which permits selective proliferation of erythroid cells (10) . We report here data which suggest appearance of increased and clonal synthesis of fetal hemoglobin in the adult erythroid cells, in vitro. METHODS Bone Marrow Cultures. Bone marrow aspirates from healthy volunteers without a hemoglobinopathy and from a patient homozygous for hemoglobin S were used; on a few occasions ribs surgically removed from patients were the source of marrow cells. Cells were washed in medium NCTC-109 (Microbiological Associates, Bethesda, Md.) containing 2% (vol/vol) fetal calf serum, penicillin (50 units/ml) and streptomycin (50 ,gg/ml); the buffy coat layers were removed, and resuspended in fresh media. Nucleated cells (5 X (13) with the exception that incubations were carried out for 2 hr. After addition of nonradioactive Hb F, part of the sample was converted to globin and chains were separated on carboxymethyl(CM)-cellulose columns (14, 15) . Another part was subjected to ion exchange chromatography on carboxymethyl(CM)-Sephadex (16); hemoglobins F and A were isolated, converted to globin, and globin chains separated. The globin columns were monitored for radioactivity in the eluates by adding 1 ml of each fraction to 10 ml of Biofluor (New England Nuclear, Boston, Mass.) and radioactivity was determined in a Packard scintillation spectrometer. Fractions from hemoglobin columns were processed for liquid scintillation counting, as previously described (13) .
For studies of globin synthesis in clot cultures, 1 X 107 to 1.5 X 107 nucleated cells were cultured in plasma clots. Cultures were labeled by adding 10 ,gCi of [3H]leucine (specific activity 80 Ci/mmol) per clot at day 6 or 7. Twenty-four hours later, the cultures were harvested; clots were extensively rinsed in large volumes of phosphate-buffered saline at pH 7.0, suspended in a small volume of distilled water, disrupted by sonication followed by freeze-thawing, and centrifuged at 23,000 X g. Nonradioactive Hb Fo and Ao (or So) were added to the supernates. The lysates were first subjected to gel filtration, and then to isolation of hemoglobins by CM-Sephadex chromatography; globin chains were then separated by CM-cellulose chromatography (14, 15) . Alternatively, after CM-Sephadex chromatography of lysates, gel filtration of hemoglobins or globins and separation of chains were performed. Gel filtration of hemoglobins was carried out at 4°in 2.5 X 100 cm columns of Sephadex G-100 equilibrated and developed with 0.05 M Tris-HCl, at pH 7.4 (13) . Gel filtration of globins was performed in 2.5 X 100 cm columns of Sephadex G-100 equilibrated and developed with 20% (vol/vol) formic acid (15) . Radioactivity was monitored in the chromatographic fractions as mentioned above.
RESULTS
Immunofluorescent labeling of the plasma clots permitted the identification of hemoglobins synthesized in individual colonies. After reaction with anti-Hb A antibody conjugated with FITC (anti-Hb A-FITC), all the erythroid colonies fluoresced, indicating that, as expected, Hb A is synthesized in all the erythroid cells in culture. In contrast, reaction with anti-Hb F-FITC revealed a different picture: a heterogeneous distribution of Hb F among the erythroid colonies, with only a few colonies binding the antibody and emitting moderate to bright fluorescence (Fig 1) .
In addition to its restriction to a small proportion of erythroid colonies, fetal hemoglobin synthesis appeared to be clonal in the sense that all the cells of each Hb F synthesizing colony bound the anti-Hb F-FITC, displaying the same intensity of fluorescence. Occasionally when advanced maturation produced smaller normoblasts within a positive colony, the cytoplasm of these smaller cells was somewhat brighter in fluorescence than the rest of the remaining cells. There was no relationship between presence or absence of Hb F and size of the erythroid colonies.
The frequency of erythroid cells synthesizing Hb F in tivo was compared with the frequency of Hb F synthesizing colonies in vitro in 14 individuals without hemoglobinopathy and (in two experiments) in a person with sickle cell anemia. The proportions of Hb F synthesizing cells in Vivo was determined after labeling the peripheral blood (9) or the uncultured bone marrow specimens of these individuals with anti-Hb F-FITC. From 0.5% to 8% of the erythrocytes in the peripheral blood contained Hb F (Table 1 ). In the individuals without a hemoglobinopathy, from 4.3 to 29.6% of the erythroid colonies displayed bright fluorescence after they were labeled with anti-Hb F-FITC. The proportion of Hb F synthesizing colonies was several times higher than that expected from the frequency of Hb F containing red cells or erythroblasts, in mvo (Table 1) .
To examine the possibility that induced synthesis of Hb F might have occurred in culture, the radioactive globins synthesized in culture were analyzed. In three experiments, the marrow cells were of normal hemoglobin phenotype while in the fourth they were from a patient with homozygous Hb S disease. The synthesis of y chain was barely detectable in the uncultured marrow cells from the normal individuals (Table  2 ). In the uncultured marrow from the individual homozygous for Hb S, y chain synthesis was 1.3 to 1.9% of the total non-a chain synthesis. After 7-8 days in culture, significant amounts of fetal hemoglobin (Fig. 2) and of y globin (Fig. 3) were produced. The data from the four experiments are summarized in Table 2 . In cultured erythroid cells from the normal individuals, y chain synthesis increased from 5-fold to 14-fold above the in vivo baseline levels. In the person with sickle cell anemia, Table 2 ).
ratios of a and non-a chains produced in the marrow cells before and after culture. In cultures with the higher Hb F production, the ratio of synthesized a and ,3 chains indicates considerable ,B chain deficit; the ratio of a/,3+y chain production is, however, identical to the a:f3 chain ratio before culture, and suggests that the ,3 chain deficit is compensated by the newly produced y chains. The increased y chain synthesis does not result from a disordered production of y chains, but rather increased y mRNA and decreased ,3 mRNA production are so regulated as to keep the total globin chain synthesis balanced. The evidence for cellular restriction of Hb F is provided by the results of immunofluorescent labeling with anti-Hb F-FITC, which show a clonal appearance of fetal hemoglobin in erythroid colonies. In a given Hb F containing colony, all the cells reacted with the fluorescent antibody to a similar extent which indicates that they had similar Hb F contents. Because, among the Hb F containing colonies there were small ones consisting of [8] [9] [10] [11] [12] [13] [14] [15] [16] cells and large colonies containing over 100 cells, production of fetal hemoglobin appears independent of the number of cell divisions or the rate of erythroid cell proliferation. It seems, thus, that all cells of each colony were programmed for similar amounts of y chain formation. This suggests that the information for the turning on of y chain synthesis was present in the original cells from which each colony was derived. The erythroid colonies in plasma clots are, most probably, initiated by erythropoietin-responsive committed stem cells (1012); the findings of the immunochemical study suggest that the ability for y gene transcription is determined at least at the level of this erythroid cell precursor.
Increased synthesis of Hb F (20) or persistence of y chain synthesis (21) in intro has been reported but was not confirmed (22) . The discrepancy between the present and previous (22) data may reflect differences in the experimental system. Previous work has utilized suspension bone marrow culture systems in which erythroid cell proliferation is limited and globin chain synthesis progressively declines (20) (21) (22) . In contrast, the culture system used in this study permits 
